298 related articles for article (PubMed ID: 22561450)
1. The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).
Muñoz MC; Giani JF; Burghi V; Mayer MA; Carranza A; Taira CA; Dominici FP
Regul Pept; 2012 Aug; 177(1-3):1-11. PubMed ID: 22561450
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.
Muñoz MC; Giani JF; Dominici FP
Regul Pept; 2010 Apr; 161(1-3):1-7. PubMed ID: 20188769
[TBL] [Abstract][Full Text] [Related]
3. ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.
Prasannarong M; Santos FR; Henriksen EJ
Biochem Biophys Res Commun; 2012 Sep; 426(3):369-73. PubMed ID: 22960175
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
Giani JF; Gironacci MM; Muñoz MC; Peña C; Turyn D; Dominici FP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1154-63. PubMed ID: 17496209
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.
Fu Z; Zhao L; Aylor KW; Carey RM; Barrett EJ; Liu Z
Hypertension; 2014 Jun; 63(6):1219-27. PubMed ID: 24711523
[TBL] [Abstract][Full Text] [Related]
6. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats.
Giani JF; Mayer MA; Muñoz MC; Silberman EA; Höcht C; Taira CA; Gironacci MM; Turyn D; Dominici FP
Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E262-71. PubMed ID: 19001546
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
9. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas.
Morales MG; Abrigo J; Acuña MJ; Santos RA; Bader M; Brandan E; Simon F; Olguin H; Cabrera D; Cabello-Verrugio C
Dis Model Mech; 2016 Apr; 9(4):441-9. PubMed ID: 26851244
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells.
Su Z; Zimpelmann J; Burns KD
Kidney Int; 2006 Jun; 69(12):2212-8. PubMed ID: 16672906
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
13. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
[TBL] [Abstract][Full Text] [Related]
14. The Angiotensin-(1-7)/Mas Axis Improves Pancreatic β-Cell Function in Vitro and in Vivo.
Sahr A; Wolke C; Maczewsky J; Krippeit-Drews P; Tetzner A; Drews G; Venz S; Gürtler S; van den Brandt J; Berg S; Döring P; Dombrowski F; Walther T; Lendeckel U
Endocrinology; 2016 Dec; 157(12):4677-4690. PubMed ID: 27715254
[TBL] [Abstract][Full Text] [Related]
15. The ACE2-angiotensin-(1-7)-Mas axis protects against pancreatic cell damage in cell culture.
Wang J; Liu R; Qi H; Wang Y; Cui L; Wen Y; Li H; Yin C
Pancreas; 2015 Mar; 44(2):266-72. PubMed ID: 25426615
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways.
Burns WC; Velkoska E; Dean R; Burrell LM; Thomas MC
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F585-93. PubMed ID: 20554647
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
Akhtar S; Yousif MH; Dhaunsi GS; Chandrasekhar B; Al-Farsi O; Benter IF
Br J Pharmacol; 2012 Mar; 165(5):1390-400. PubMed ID: 21806601
[TBL] [Abstract][Full Text] [Related]
18. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
[TBL] [Abstract][Full Text] [Related]
19. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
20. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7).
Santos SH; Braga JF; Mario EG; Pôrto LC; Rodrigues-Machado Mda G; Murari A; Botion LM; Alenina N; Bader M; Santos RA
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):953-61. PubMed ID: 20203301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
